KOCH KEVIN — SEC Form 4 filings
SEC reporting owner CIK 1185829. 7 Form 4 filings on record with FilingPulse; latest filed 2026-08-14.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-03 to 2026-08-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 6 filings — 43,007 shares, $1,312,084 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 8,782 shares @ $43.64 ($383,254) in Edgewise Therapeutics, Inc., filed 2026-08-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. (EWTX) | President and CEO, Director | 7 | — | 9 legs · 43,007 sh · $1,312,084 | 22 |
Form 4 filings — KOCH KEVIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 17,969 @ $0 · Option exercise (M): 21,875 @ $0 · Sale (S): 8,782 @ $43.64 · Sale (S): 8,276 @ $43.66 · Sale (S): 913 @ $44.33 · Option exercise (M): 17,969 (derivative) @ $0 · +3 more | EDGAR |
| 2025-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 17,968 @ $0 · Sale (S): 7,972 @ $13.39 · Option exercise (M): 17,968 (derivative) @ $0 · Grant/award (A): 87,500 (derivative) @ $0 · Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2025-05-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 10,417 @ $0 · Sale (S): 4,276 @ $16.45 · Option exercise (M): 10,417 (derivative) @ $0 | EDGAR |
| 2025-03-11 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 100 @ $0.18 · Sale (S): 100 @ $30 · Option exercise (M): 100 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 8,636 @ $0.18 · Sale (S): 8,636 @ $30.03 · Option exercise (M): 900 @ $13.11 · Sale (S): 900 @ $31.13 · Option exercise (M): 8,636 (derivative) @ $0 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-08-14 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 431,250 (derivative) @ $0 · Grant/award (A): 71,875 (derivative) @ $0 | EDGAR |
| 2024-05-03 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 10,417 @ $0 · Sale (S): 3,152 @ $18.91 · Option exercise (M): 10,417 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1185829 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →